From a young age, Kim Noonan knew what she wanted in life — a career in science and a desire to help.

When her mother succumbed to gastric cancer, it drove her even more to help people, especially cancer patients. Today, she’s at the forefront of a potentially game-changing development in cancer therapy — using bone marrow-infiltrating lymphocytes (MILs) designed to target and kill cancerous tumors of all shapes and sizes.

Find out how her early work with myeloma patients started her road to discovering MILs, the origin of WindMIL Therapeutics, challenges associated with manufacturing MIL-based therapies, and what the future holds for this revolutionary treatment.

Learn more about WindMIL Therapeutics and the science behind their work with bone marrow immunology.

SHOW NOTES

• Cell and Gene Therapy Services
• Oncology Research and Drug Development
• The Link Between a Consistent Cell Supply and Successful Cell Therapies
• Charles River Presents: Tailored Preclinical Support for Your Cell & Gene Therapies
• Cell and Gene Therapy Development Video Series
• Better In Vitro Cancer Models for Better Cancer Drugs
• MILs Role in Biology and Cancer Therapy

ACKNOWLEDGMENTS

Hosted by: Gina Mullane
Narrated by: Chris Garcia
Special thanks to: Kim Noonan